Pharmaceuticals News

The pharmaceuticals news email from Wiser has been specifically designed for anyone with an interest in the industry. This includes medical practitioners, investors and those involved in research and development. By its very nature, the pharmaceutical industry is subject to constant change. It is a research-driven industry with companies spending much of their revenues developing new medicines and vaccines. As a result patients are able to get new and more effective treatments. This is helping to increase the life expectancy of individuals in most countries. But there are challenges. The costs of the research and development can be large which puts up the price of drugs, while governments and the medical industry argue to try to keep prices as low as possible. The industry also faces challenges from alternatives, both legal (through generic drugs) and illegal (through black market economies). To follow the latest developments in this industry you should sign up for the pharmaceuticals news email from Wiser. It is the best way to find must-read articles on the topic from around the web.

Recent Pharmaceuticals News Coverage
 
Your Weekly Recommendations Wednesday, April 25, 2018
 
Recommended for you
EpiPen shortages seen in Canada, UK but U.S. supply intact
Reuters • Bill Berkrot
Tariffs could drive drug and medical device prices higher
Modern Healthcare • Alex Kacik
Report finds hospitals drive overall healthcare price growth
Modern Healthcare • Tara Bannow
U.S. appeals court strikes down Maryland drug price-gouging law
Reuters • Nate Raymond
U.S. appeals court strikes down Maryland drug price-gouging law
Reuters • Nate Raymond
Mylan seeks deal for Merck's consumer products unit
CNBC
Mylan seeks deal for German Merck's consumer products unit: sources
Reuters • Reuters Staff
Cross-Selling Can Drive Meaningful Growth For Medidata Solutions
Seeking Alpha • Stephen Simpson
'Unsolved Mysteries' on Display at AACR
MedPage Today
Senator calls out drugmakers for buying back stocks rather than slashing prices for consumers
Becker's Hospital Review • Kelly Gooch
 
Recommended for You
Asthma, Health Care Industry
EpiPen shortages seen in Canada, UK but U.S. supply intact
ReutersBill Berkrot
NEW YORK () - Mylan N.V.’s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment’s manufacturer said on Friday. FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical...
Share
Health Care Industry, Pharmaceuticals
Tariffs could drive drug and medical device prices higher
Modern HealthcareAlex Kacik
If President Donald Trump continues to drive up the cost of Chinese imports through new tariffs, it could roil the healthcare industry, particularly embattled generic drug manufacturers, experts said. Trump has imposed tariffs of 25% on steel and 10% on aluminum imported...
Share
Health Care Industry, Health Insurance
Report finds hospitals drive overall healthcare price growth
Modern HealthcareTara Bannow
Rising hospital price growth in March drove overall healthcare price increases to their highest rate since January 2012, according to a new report from Altarum. The Health Care Price Index rose by 2.2% last month year-over-year. Hospitals represent more than 30% of...
Share
Pharmaceuticals
U.S. appeals court strikes down Maryland drug price-gouging law
ReutersNate Raymond
() - A federal appeals court on Friday declared unconstitutional a 2017 Maryland law that lets the state attorney general sue generic drugmakers who sharply raise prices on medications. FILE PHOTO: The pharmacy department drop-off station at the Safeway store in Wheaton,...
Share
Health Care Industry, Pharmaceuticals
U.S. appeals court strikes down Maryland drug price-gouging law
ReutersNate Raymond
() - A federal appeals court on Friday declared unconstitutional a 2017 Maryland law that lets the state attorney general sue generic drugmakers who sharply raise prices on medications. FILE PHOTO: The pharmacy department drop-off station at the Safeway store in Wheaton,...
Share
Merck & Co., Inc., Pharmaceuticals
Mylan seeks deal for Merck's consumer products unit
CNBC
Mylan is in advanced discussions to acquire Merck's consumer health business, sources say.
Share
Health Care Industry, Pharmaceuticals
Mylan seeks deal for German Merck's consumer products unit: sources
ReutersReuters Staff
FRANKFURT/NEW YORK () - Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA’s consumer health business after other bidders failed to meet the German company’s price expectations, people familiar with the matter said. FILE PHOTO: A logo of...
Share
Pharmaceuticals
Cross-Selling Can Drive Meaningful Growth For Medidata Solutions
Seeking AlphaStephen Simpson
Summary Medidata appears to have around 50% share in its core business, but there is a much larger, mostly untapped market out there that can support multiyear double-digit revenue growth. Data management and clinical trial monitoring are becoming increasingly complex, and Medidata...
Share
Cancer, Epidemiology
'Unsolved Mysteries' on Display at AACR
MedPage Today
CHICAGO -- "Unsolved Mysteries" has the ring of a true-crime program from TV, but scientists-turned-sleuths will have the starring roles in the aptly named sessions at the American Association for Cancer Research (AACR) annual meeting. Returning for encore presentations, three "Unsolved Mysteries"...
Share
Finance, Investment Industry
Senator calls out drugmakers for buying back stocks rather than slashing prices for consumers
Becker's Hospital ReviewKelly Gooch
An analysis by Sen. Cory Booker, D-N.J., suggests the nation's largest pharmaceutical companies do not plan to use new tax savings to lower prescription drug prices for consumers. For the 15-page analysis, Mr. Booker's office examined transcripts of the fourth-quarter 2017 earnings...
Share